Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma: An Observer-blinded, Randomized Controlled Trial

NCT04898712 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04898712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma: An Observer-blinded, Randomized Controlled Trial
Lead sponsor
Unity Health Toronto
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2021
Completion date
December 31, 2023
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma